Solutions: Extend trial to 6 months before concluding inefficacy (some benefits take longer), increase dosing within safe ranges if using lower end, switch peptides (try Cerebrolysin if using BPC-157, or vice versa), add comprehensive eye exam to rule out progression versus peptide failure, consider peptides preventing worsening rather than producing improvement, discontinue if truly no benefit after 6 months rigorous trial
There is no compelling evidence to indicate that antioxidants reduce allergy symptoms severity or slow disease progression
It's like having a doctor who never forgets a detail and is available 24/7 in all 50 states for less than $40
Blood carries oxygen and nutrients
Working without a complete setup increases the chance of contamination or errors
The capacity of vitamin C to influence the methylation status of DNA and histones in mammalian cells supports a role for the vitamin in health and disease beyond what was previously understood, in particular by safeguarding genome integrity (3, 4)
